Evidence map›Paper›PMID 36620034›Full record

ArticleFrontiers in microbiology2022

The

Jonatas Erick Maimoni Campanella, Thiago de Souza Candido, Luiz Carlos Bertucci Barbosa, Antoniel Augusto Severo Gomes, Carla Andréa Leite, Erika Silva Higashi, Paula Aboud Barbugli, Marcos Roberto de Matos Fontes, Maria Célia Bertolini

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jonatas Erick Maimoni CampanellaDepartamento de Bioquímica e Química Orgânica, Instituto de Química, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Thiago de Souza CandidoDepartamento de Bioquímica e Química Orgânica, Instituto de Química, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Luiz Carlos Bertucci BarbosaDepartamento de Bioquímica e Química Orgânica, Instituto de Química, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Antoniel Augusto Severo GomesDepartamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, Botucatu, São Paulo, Brazil.
Carla Andréa LeiteDepartamento de Bioquímica e Química Orgânica, Instituto de Química, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Erika Silva HigashiDepartamento de Bioquímica e Química Orgânica, Instituto de Química, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Paula Aboud BarbugliDepartamento de Materiais Dentários e Prótese, Faculdade de Odontologia, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Marcos Roberto de Matos FontesDepartamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, Botucatu, São Paulo, Brazil.
Maria Célia BertoliniDepartamento de Bioquímica e Química Orgânica, Instituto de Química, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Universidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclins are a family of proteins characterized by possessing a cyclin box domain that mediates binding to cyclin dependent kinases (CDKs) partners. In this study, the search for a partner cyclin of the PHO85-1 CDK retrieved PCL-1 an ortholog of yeast Pcls (for Pho85 cyclins) that performs functions common to Pcls belonging to different cyclin families. We show here that PCL-1, as a typical cyclin, is involved in cell cycle control and cell progression. In addition, PCL-1 regulates glycogen metabolism; Δ

Indexed as

CDK/cyclin complexCRZ-1 transcription factorNeurospora crassaprotein phosphorylationstress response

Identifiers

PMID36620034
PMCPMC9815767
OpenAlexW4312081150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.